Alkermes plc. — Investor Relations & Filings
Alkermes plc is a global biopharmaceutical company that develops and commercializes medicines for diseases of the central nervous system (CNS). The company's research and development efforts focus on complex psychiatric and neurological disorders. Its portfolio includes treatments for conditions such as schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. Alkermes' clinical-stage pipeline features investigational therapies, including orexin 2 receptor agonists for sleep disorders like narcolepsy and idiopathic hypersomnia. The company's commercialized products include olanzapine and samidorphan, an oral atypical antipsychotic drug for adults with schizophrenia or bipolar I disorder.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-20 | English | |
| 8-K - Alkermes plc. (0001520262) (Filer) | 2026-05-12 | English | |
| 8-K - Alkermes plc. (0001520262) (Filer) | 2026-05-05 | English | |
| 8-K/A - Alkermes plc. (0001520262) (Filer) | 2026-05-01 | English | |
| ARS - Alkermes plc. (0001520262) (Filer) | 2026-04-06 | English | |
| DEF 14A - Alkermes plc. (0001520262) (Filer) | 2026-04-06 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NUTEX Investments Plc
An investment company in the health and wellness sector off…
|
NUTEX | HU | Manufacturing |
|
NutriBand Inc.
Biopharmaceutical firm developing abuse-deterrent transderm…
|
NTRB | US | Manufacturing |
|
Nuvalent, Inc.
Clinical-stage company developing kinase inhibitors for dru…
|
NUVL | US | Manufacturing |
|
Nuvation Bio Inc.
Biopharmaceutical company developing and commercializing no…
|
NUVB | US | Manufacturing |
|
Nuvectis Pharma, Inc.
A clinical-stage biopharmaceutical company developing targe…
|
NVCT | US | Manufacturing |
|
Nventa Biopharmaceuticals Corporation
Focused on developing therapeutics for viral infections and…
|
NVN | CA | Manufacturing |
|
Nxera Pharma Co., Ltd.
A technology-driven biopharma company focused on discoverin…
|
4565 | JP | Manufacturing |
|
Nykode Therapeutics ASA
Clinical-stage biopharma developing novel immunotherapies f…
|
NYKD | NO | Manufacturing |
|
ObsEva SA
Clinical-stage biopharma for women's health, now winding do…
|
OBSN | CH | Manufacturing |
|
Ocugen, Inc.
Develops gene/cell therapies for blindness and vaccines for…
|
OCGN | US | Manufacturing |
Alkermes plc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31048/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31048 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31048 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31048 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31048}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alkermes plc. (id: 31048)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.